|Publication number||US4411657 A|
|Application number||US 06/353,517|
|Publication date||Oct 25, 1983|
|Filing date||Mar 1, 1982|
|Priority date||May 19, 1980|
|Publication number||06353517, 353517, US 4411657 A, US 4411657A, US-A-4411657, US4411657 A, US4411657A|
|Original Assignee||Anibal Galindo|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (3), Referenced by (130), Classifications (6), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This is a continuation of application Ser. No. 151,378, filed May 19, 1980.
This invention relates generally to a hypodermic needle that is useful for applying a local anesthetic to block nerve transmission, otherwise known as regional anesthesia.
Conventional hypodermic needles have a blade-like tip for penetrating the flesh, the tip having the orifice through which anesthetic or other liquid is ejected. It has been found that trauma to nerve fascicles results due to the slicing action of the conventional needle tip which literally cuts into the nerves themselves. Any direct intraneural injection resulting from cutting into the nerve and the tremendous fluid pressure through the orifice can result in post block nerve injuries. A study of causes of post anesthetic nerve damage (nerve palsy) suggests three major problems: (1) Direct damage to the nerve by the cutting edge of a conventional needle; (2) Neural trauma by high pressure intraneural injection of a local anesthetic resulting from the cutting and the position of the needle orifice, and (3) the toxic effect of the anesthetic or its perservatives from being subjected directly onto the interior of the nerve.
The present invention overcomes or minimizes the first two possibilities. This is accomplished by utilization of an improved needle tip which does not pierce or slice into the nerve fascicle nor permit an intraneural injection but instead allows for injection in the perineural space between the nerve fascicles.
A hypodermic needle having an elongated, rigid shaft of a predetermined length and diameter, said shaft including a hollow, interior passage, that terminates prior to the tip of the needle. One end of the needle is fastened to a conventional syringe. The tip end of the needle is a solid, conically-shaped point having predetermined dimensions. Disposed back from the tip are openings along the circumferential body of the needle that are spaced strategically from the tip such that the injection liquid is dispensed at approximately a 90° angle to the longitudinal axis of the needle shaft.
The conical shape and size of the needle tip is such that it will pass between the nerve fascicles rather than slice through them. During the penetration of the needle, the tip, of its shape and size, can force aside individual nerve fascicles, allowing penetration into a given nerve block without cutting. Subsequent dispensing of the anesthesia or other suitable liquids through one or more laterally facing orifices (relative to the needle shaft) greatly reduces the liquid pressure on nerve fascicles immediately surrounding each orifice.
In the preferred embodiment, the improved needle has a pointed conical tip between two to four millimeters long the final one or two millimeters being solid, followed by a plurality of circular orifices at a variable distance of no more than four millimeters from the solid tip, or by an elongated, elliptical opening (0.3 to 0.5 millimeters wide) for ejection of the anesthesia. The initial orifice from the solid tip may be placed either immediately, one millimeter or two millimeters, longitudinally from the point. Two or more orifices for achieving three openings in each needle may be located at one millimeter intervals around the needle circumference, but not in the same axial plane. If the elliptically slotted needle is preferred, slots may be located anywhere between beginning immediately behind the solid point periphery up to two millimeters behind this position. The needle gauges may be varied depending on the type of nerve block to be anesthetized and the particular build of the patient.
Experiments were conducted in situ sciatic nerves of anesthesized rabbits. Under direct visual observation, nerves were penetrated at intervals of ten millimeters with a conventional (short bevelled) 22 gauge hypodermic needle. This needle was advanced transversely or perpendicularly over the largest bundle of nerve fascicles. Other nerves were penetrated in a similar manner with a 22 gauge needle constructed in accordance with the present invention described herein. The nerves were bathed for two hours using a solution of five (5) percent bovine albumin tagged with one (1) percent Evans blue as described by Selander et al "Peripheral Nerve Injury Due To Injection Needles Used For Regional Anesthesia" Acta Anesthesia Scand 21:182-188, 1977. Damage to the nerve was assessed by observing and counting under the microscope the number of times that the penetration of the needles cut one or more nerve fascicles; fluorescence microscope, dark field condenser and special lamp were used following Selander et al and Steinwalt and Klatzo "Selected Vulnerability of the Blood-Brain Barrier In Chemically Induced Lesions", J. Neuropath. Exp. neural 25:542-560, 1966.
To other sciatic nerves, intraneural injections of 0.1 cc of 0.1% methylene blue solution was tried 10 times each with a regular short bevelled hypodermic needle and with the improved needle in accordance with this invention, both 0.7 millimeters in diameter (22 gauge). The degree of penetration of the anesthetic solution into the nerve was graded as (1) minimal, (2) penetration in a radius of less than 10 millimeters, and (3) penetration with a migration of more than 10 milimeters. Results of the observations are embodied in Table 1 of FIG. 8. Fluid pressures of injection through the needle alone when the tip was located inside the muscle, the perineural space, and the nerve were measured using a constant infusion pump to inject a normal saline solution contained in a 50 cc syringe and delivered at a speed of 15.3 cc's per minute for a maximum of 4 seconds. A Stathan pressure transducer connected to a two-channel graph recorder was used for pressure determination.
To summarize the results and conclusions, it can be seen from Table 8 that the penetration damage to the nerve using the improved hypodermic needle is greatly reduced and eliminated. Using the improved needle, in accordance with the present invention, the die could not be injected inside the nerve but was ejected through orifices or (part of the slot) outside of the nerve thus the pressure of injection with the tip of the needle inside the nerve was approximately 400 millimeters Hg lower with the needle in accordance with the present invention which was injecting perineurally than with the conventional needle that was injecting intraneurally.
In an alternate embodiment the improved needle in accordance with the principles of the invention can be modified for use to localize electrically the nerves to be blocked through mild electrical stimulation. In this embodiment the shaft of the needle (but not the tip) is coated with a fine (0.01 milimeter) film of tygon (or other comparable insulating material) or a plastic sleeve placed for the same purposes along the shaft of the needle, leaving the solid tip bare. The plastic sleeve may be left in-situ after withdrawing the needle; this would allow repeated injections of the anesthetic. A small five millimeter bar or small wings are built into the hub of the needle to facilitate wiring to a nerve stimulator; the circuit is closed through a cable connecting the skin to the stimulator's ground. With proper auxiliary equipment the insulated needle can be used as a stimulating or recording electrode to perform precise injection of local anesthetic solutions.
It is an object of this invention to provide an improved hypodermic needle for use with a conventional syringe that reduces or eliminates trauma or damage to the nerve.
It is another object of this invention to provide an improved hypodermic needle which prevents cutting or traumatic nerve fascicles by intraneural injection of local anesthetics.
And yet still another object of this invention is to provide an improved hypodermic needle that reduces the pressure adjacent to the surrounding tissue when administering a local anesthesia by providing for perineural dispensing rather than intraneural dispensing of the anesthesia.
But yet still another object of this invention is to provide a hypodermic needle having a solid, pointed tip, with the fluid ejection orifices being disposed to eject fluid perpendicular to the longitudinal axis of the needle body.
In accordance with these and other objects which will be apparent hereinafter, the instant invention will now be described with particular reference to the accompanying drawings.
FIG. 1 shows a side elevational view of the present invention.
FIG. 2 shows a side elevational, fragmentary view of a needle tip in accordance with the present invention.
FIG. 3 shows a fragmentary side elevational view of a needle tip in accordance with the present invention.
FIG. 4 shows a side elevational view of a hypodermic needle constructed in accordance with the view of FIG. 3 with the axis rotated 90° of the shaft.
FIG. 5 shows an alternate embodiment of the present invention in a side elevational fragmentary view.
FIG. 6 shows yet another alternate embodiment of the present invention in a side elevational view.
FIG. 7 shows an alternate embodiment of the present invention utilizing and providing electrical stimulation.
FIG. 8 shows a table comparing experimental results between a conventional hypodermic needle and a needle constructed in accordance with the present invention.
FIG. 9 shows a fragmentary plastic sleeve covering the shaft of the needle.
Referring now to the drawings and particularly to FIG. 1, the new and improved hypodermic needle is shown generally at 10. The hypodermic needle 10 comprises a hub 12, a hollow, elongated, rigid shaft 14, with a plurality of holes 18 near the tip end 16. The tip end 16 has a conically shaped point which can be introduced into the nerve without causing damage to the nerve. As shown in FIG. 2 the tip end 16 is comprised of a solid portion with a conically shaped point 20 and a hollow portion 22. The design of the tip end 16 with a solid point 20 enables it to force aside individual nerve fascicles allowing penetration to a given nerve without cutting the nerve. The needle 10 has a sharp pinpoint of two to four millimeters in length with a solid portion (cone-shaped) being one or two millimeters in length. The angle of the cone-shaped portion may vary between 90° maximum and 6° minimum. The diameter of the hollow elongated shaft 14 is 0.3 millimeters or 0.7 millimeters depending upon the application.
Referring now to FIGS. 3, 4, 5, and 6 various designs of passages to allow the passage of fluids from the needle into the body are shown. In FIGS. 3 and 4, a plurality of holes at a variable distance but no more than four millimeters from the solid tip are shown. The positions of the holes 18 enable the fluid to be injected paraneurally rather than intraneurally as accidentally has been done in the past, since the presence of the nerve over one or more of the holes keeps the fluid from passing therethrough and causes the fluid to be released through one or more of the remaining holes 18 which are not across the nerve. The same problem can be solved also by using an elongated eliptically shaped slot which is normally from 0.3 to 0.5 millimeters in width for injecting the fluid. Again the portion of the elongated slot which is in the nerve will not allow passage of the fluid into the nerve because of the pressure of the nerve thereon and thus the fluid will be injected paraneurally rather than intraneurally. The slot 24 will be located beginning immediately behind the solid point 20 or up to two millimeters behind this point.
Referring now to FIG. 7, the hypodermic needle 10 can be modified for use to localize electrically the nerves to be blocked by mild electrical stimulation. The shaft 14 of the needle 10 is coated with a fine (0.01 millimeter) film of tygon or other comparable insulating material along the shaft of the needle 10 leaving the solid tip 16 non-insulated. A small 5 millimeter bar 30 or small wings are built into the hub to facilitate connection to a nerve stimulator 26. The nerve stimulator circuit 26 is closed through a cable connecting the skin to the stimulator's ground. With proper auxilliary equipment, the insulated needle 14 can be used as a stimulating or a recording electrode to perform precise injection of local anesthetic solutions.
As shown in FIG. 9, a plastic sleeve may also be used to insulate the needle 14. The plastic sleeve 32 is slidably engaged with the needle 14 and may be left in-situ after withdrawing the needle, thus allowing repeated injections of the local anesthetic or to reinforce a difficult block.
The instant invention has been shown and described herein in what is considered to be the most practical and preferred embodiment. It is recognized, however, that departures may be made therefrom within the scope of the invention and that obvious modifications will occur to a person skilled in the art.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3078850 *||Aug 26, 1960||Feb 26, 1963||Imp Electronics Inc||Electrochemotherapeutic cardiac device|
|US3313293 *||Jan 13, 1964||Apr 11, 1967||Hewlett Packard Co||Multi-electrode needle|
|US3727613 *||Oct 9, 1970||Apr 17, 1973||Voys Inc Le||Safety catheter placement assembly|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4699612 *||Apr 1, 1985||Oct 13, 1987||Hamacher Edward N||Infusion needle|
|US4710180 *||Oct 6, 1986||Dec 1, 1987||Johnson Gerald W||Lipoject needle|
|US4717380 *||Dec 23, 1985||Jan 5, 1988||Baumgartner George C||Method and apparatus for medically treating recessed body tissue|
|US4790830 *||Jul 24, 1987||Dec 13, 1988||Hamacher Edward N||Infusion needle|
|US4989614 *||Feb 23, 1988||Feb 5, 1991||Vance Products Incorporated||Fine-needle aspiration cell sampling methods|
|US5100402 *||Oct 5, 1990||Mar 31, 1992||Megadyne Medical Products, Inc.||Electrosurgical laparoscopic cauterization electrode|
|US5254106 *||Apr 17, 1992||Oct 19, 1993||Feaster Fred T||Hydrodissection needle|
|US5273525 *||Aug 13, 1992||Dec 28, 1993||Btx Inc.||Injection and electroporation apparatus for drug and gene delivery|
|US5360416 *||Sep 30, 1993||Nov 1, 1994||Sherwood Medical Company||Thin-walled anesthesia needles|
|US5478328 *||Sep 2, 1993||Dec 26, 1995||Silverman; David G.||Methods of minimizing disease transmission by used hypodermic needles, and hypodermic needles adapted for carrying out the method|
|US5484417 *||Nov 30, 1994||Jan 16, 1996||Biotime, Inc.||Microcannula|
|US5549112 *||Mar 9, 1995||Aug 27, 1996||Cockburn; John F.||Medical needle for use in ultrasound imaging and method of enhancing the visibility of such a needle to ultrasound|
|US5562613 *||Jul 6, 1994||Oct 8, 1996||Intermed, Inc.||Subcutaneous drug delivery device|
|US5662619 *||Nov 27, 1995||Sep 2, 1997||Zarate; Alfredo R.||Venous dialysis needle|
|US5688246 *||Oct 24, 1995||Nov 18, 1997||Biotime, Inc.||Microcannula|
|US5728124 *||Aug 27, 1996||Mar 17, 1998||Cockburn; John Francis||Medical needle for use in ultrasound imaging and method of enhancing the visiblity of such a needle to ultrasound|
|US5738650 *||Aug 22, 1995||Apr 14, 1998||Becton, Dickinson And Company||Subarachnoid needle and method for administering therapeutic agents to the subarachnoid space|
|US5792123 *||Jul 24, 1997||Aug 11, 1998||Michigan Transtech Corporation||Implantable access devices|
|US5807304 *||Dec 31, 1996||Sep 15, 1998||Cockburn; John F.||Medical needle for use in ultrasound imaging|
|US5819497 *||Feb 20, 1997||Oct 13, 1998||Knepper; Richard T.||Method and device for repairing fasteners attached to plaster board|
|US5848996 *||May 19, 1997||Dec 15, 1998||Eldor; Joseph||Multiple hole spinal needle|
|US5906599 *||Nov 9, 1995||May 25, 1999||Intermed, Inc.||Device for delivering biological agents|
|US6090107 *||Oct 20, 1998||Jul 18, 2000||Megadyne Medical Products, Inc.||Resposable electrosurgical instrument|
|US6159163 *||May 7, 1998||Dec 12, 2000||Cedars-Sinai Medical Center||System for attenuating pain during bone marrow aspiration and method|
|US6241710||Dec 20, 1999||Jun 5, 2001||Tricardia Llc||Hypodermic needle with weeping tip and method of use|
|US6248196||Nov 12, 1997||Jun 19, 2001||Biotime, Inc.||Method for making a microcannula|
|US6258070||Mar 11, 1999||Jul 10, 2001||Intermed, Inc.||Device for delivering biological agents|
|US6280424 *||Dec 21, 1999||Aug 28, 2001||Ethicon, Inc.||Apparatus and method for using a needle in an intravascular assembly|
|US6371943 *||Jul 14, 1999||Apr 16, 2002||Epimed International, Inc.||Spring tip needle combination|
|US6391014 *||Dec 19, 1997||May 21, 2002||David G. Silverman||Strong diaphragm/safe needle/converting device combinations and their individual components|
|US6511479||Feb 27, 2001||Jan 28, 2003||Conmed Corporation||Electrosurgical blade having directly adhered uniform coating of silicone release material and method of manufacturing same|
|US6517521 *||Apr 19, 2000||Feb 11, 2003||Keith K. Ly||Painless perforated intradermal injection needle|
|US6528315||Jun 30, 1998||Mar 4, 2003||Aventis Pharma S.A.||Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor|
|US6547769||Apr 9, 2001||Apr 15, 2003||Tricardia Llc||Catheter apparatus with weeping tip and method of use|
|US6659996||Sep 27, 1999||Dec 9, 2003||Intermed, Inc.||Device for delivering biological agents|
|US6855132||Jan 14, 2003||Feb 15, 2005||Tricardia, Llc||Apparatus with weeping tip and method of use|
|US6878136||Jan 24, 2003||Apr 12, 2005||Medical Product Specialists||Huber needle with anti-rebound safety mechanism|
|US6890319||Aug 13, 1999||May 10, 2005||Imprint Pharmaceuticals Ltd.||Apparatus for delivering a substance having one or more needles driven at high velocity|
|US6918894||Feb 28, 2003||Jul 19, 2005||Medical Product Specialists||Huber needle with anti-rebound safety mechanism|
|US6939862||Nov 7, 2001||Sep 6, 2005||Aventis Pharma S.A.||Method for transferring nucleic acid into striated muscles|
|US6949087||May 26, 2004||Sep 27, 2005||Tricardia, Llc||Apparatus with weeping tip and method of use|
|US6969373||Sep 28, 2001||Nov 29, 2005||Tricardia, Llc||Syringe system|
|US7252654||Sep 2, 2005||Aug 7, 2007||Tricardia, Llc||Apparatus with weeping tip and method of use|
|US7455664||Jun 21, 2007||Nov 25, 2008||Mps Acacia||Huber needle with anti-rebound safety mechanism|
|US7588557||Sep 24, 2003||Sep 15, 2009||Granit-Medical Innovations, Llc||Medical instrument for fluid injection and related method|
|US7666172 *||Mar 15, 2005||Feb 23, 2010||Plaridel Cerna Atil||Medical needle having a closed tip|
|US7935092||Jul 25, 2006||May 3, 2011||Twin Star Medical, Inc.||Self-introducing injection and aspiration device|
|US8177748||Jun 15, 2004||May 15, 2012||Advanced Cardiovascular Systems, Inc.||Systems and methods for detecting tissue contact and needle penetration depth|
|US8257324||May 21, 2007||Sep 4, 2012||Georgia Tech Research Corporation||Microneedle drug delivery device|
|US8574195 *||Sep 5, 2003||Nov 5, 2013||Advanced Cardiovascular Systems, Inc.||Systems and methods for detecting tissue contact and needle penetration depth using static fluid pressure measurements|
|US8708966||Aug 9, 2010||Apr 29, 2014||Georgia Tech Research Corporation||Microneedle devices and methods of manufacture and use thereof|
|US8980864||Dec 20, 2013||Mar 17, 2015||Moderna Therapeutics, Inc.||Compositions and methods of altering cholesterol levels|
|US8999380||Mar 9, 2013||Apr 7, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides for the production of biologics and proteins associated with human disease|
|US9050297||Dec 16, 2013||Jun 9, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator|
|US9061059||Feb 3, 2014||Jun 23, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides for treating protein deficiency|
|US9089604||Feb 3, 2014||Jul 28, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides for treating galactosylceramidase protein deficiency|
|US9095552||Dec 12, 2013||Aug 4, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1|
|US9107886||Dec 12, 2013||Aug 18, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides encoding basic helix-loop-helix family member E41|
|US9114113||Dec 12, 2013||Aug 25, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides encoding citeD4|
|US9149506||Dec 16, 2013||Oct 6, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides encoding septin-4|
|US9149573 *||Mar 16, 2007||Oct 6, 2015||Smiths Medical Asd, Inc.||Blunt cannula for accessing a slit septum|
|US9181319||May 6, 2014||Nov 10, 2015||Moderna Therapeutics, Inc.||Engineered nucleic acids and methods of use thereof|
|US9186372||May 21, 2013||Nov 17, 2015||Moderna Therapeutics, Inc.||Split dose administration|
|US9192651||Mar 9, 2013||Nov 24, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides for the production of secreted proteins|
|US9216205||Dec 16, 2013||Dec 22, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides encoding granulysin|
|US9220755||Dec 13, 2013||Dec 29, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders|
|US9220792||Dec 11, 2013||Dec 29, 2015||Moderna Therapeutics, Inc.||Modified polynucleotides encoding aquaporin-5|
|US9221891||Mar 15, 2013||Dec 29, 2015||Moderna Therapeutics, Inc.||In vivo production of proteins|
|US9233141||Dec 12, 2013||Jan 12, 2016||Moderna Therapeutics, Inc.||Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders|
|US9254311||Mar 9, 2013||Feb 9, 2016||Moderna Therapeutics, Inc.||Modified polynucleotides for the production of proteins|
|US9255129||Dec 16, 2013||Feb 9, 2016||Moderna Therapeutics, Inc.||Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1|
|US9271996||May 18, 2013||Mar 1, 2016||Moderna Therapeutics, Inc.||Formulation and delivery of PLGA microspheres|
|US9283287||Apr 23, 2015||Mar 15, 2016||Moderna Therapeutics, Inc.||Modified polynucleotides for the production of nuclear proteins|
|US9295689||May 18, 2013||Mar 29, 2016||Moderna Therapeutics, Inc.||Formulation and delivery of PLGA microspheres|
|US9301993||Dec 16, 2013||Apr 5, 2016||Moderna Therapeutics, Inc.||Modified polynucleotides encoding apoptosis inducing factor 1|
|US9302903||Dec 14, 2001||Apr 5, 2016||Georgia Tech Research Corporation||Microneedle devices and production thereof|
|US9303079||Mar 9, 2013||Apr 5, 2016||Moderna Therapeutics, Inc.||Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins|
|US9308020 *||Mar 4, 2014||Apr 12, 2016||Cook Medical Technologies Llc||Tri-fluted vascular access needle|
|US9334328||Jan 11, 2013||May 10, 2016||Moderna Therapeutics, Inc.||Modified nucleosides, nucleotides, and nucleic acids, and uses thereof|
|US9428535||Oct 3, 2012||Aug 30, 2016||Moderna Therapeutics, Inc.||Modified nucleosides, nucleotides, and nucleic acids, and uses thereof|
|US9447164||Oct 8, 2015||Sep 20, 2016||Moderna Therapeutics, Inc.||Engineered nucleic acids and methods of use thereof|
|US9464124||Nov 5, 2014||Oct 11, 2016||Moderna Therapeutics, Inc.||Engineered nucleic acids and methods of use thereof|
|US9533047||Jul 22, 2014||Jan 3, 2017||Modernatx, Inc.||Delivery and formulation of engineered nucleic acids|
|US9572897||Feb 12, 2016||Feb 21, 2017||Modernatx, Inc.||Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins|
|US9587003||Feb 4, 2016||Mar 7, 2017||Modernatx, Inc.||Modified polynucleotides for the production of oncology-related proteins and peptides|
|US9597380||Oct 2, 2013||Mar 21, 2017||Modernatx, Inc.||Terminally modified RNA|
|US9657295||Apr 29, 2016||May 23, 2017||Modernatx, Inc.||Modified nucleosides, nucleotides, and nucleic acids, and uses thereof|
|US9675668||Dec 13, 2013||Jun 13, 2017||Moderna Therapeutics, Inc.||Modified polynucleotides encoding hepatitis A virus cellular receptor 2|
|US9701965||Nov 7, 2014||Jul 11, 2017||Modernatx, Inc.||Engineered nucleic acids and methods of use thereof|
|US9782462||Mar 4, 2016||Oct 10, 2017||Modernatx, Inc.||Modified polynucleotides for the production of proteins associated with human disease|
|US9814760||Oct 8, 2015||Nov 14, 2017||Modernatx, Inc.||Modified polynucleotides for the production of biologics and proteins associated with human disease|
|US20020082543 *||Dec 14, 2001||Jun 27, 2002||Jung-Hwan Park||Microneedle devices and production thereof|
|US20030130626 *||Jan 14, 2003||Jul 10, 2003||Vantassel Robert A.||Apparatus with weeping tip and method of use|
|US20040073197 *||Jul 9, 2003||Apr 15, 2004||Kim Philip S.||Selective peripheral nerve plexus implantable infusion device and method|
|US20040082922 *||Oct 17, 2003||Apr 29, 2004||Fleury Michael T.||Huber needle with anti-rebound safety mechanism|
|US20040092893 *||Sep 10, 2003||May 13, 2004||Haider M. Ishaq||Method and apparatus for epidermal delivery of a substance|
|US20040147881 *||Jan 24, 2003||Jul 29, 2004||Hyun Dongchul D.||Huber needle with a manually movable sleeve member for containing its injection point|
|US20040184989 *||Jan 30, 2004||Sep 23, 2004||Thomas Jefferson University||Intratumoral delivery device|
|US20040220536 *||May 26, 2004||Nov 4, 2004||Vantassel Robert A.||Apparatus with weeping tip and method of use|
|US20040260240 *||Sep 5, 2003||Dec 23, 2004||Dagmar Beyerlein||Systems and methods for detecting tissue contact and needle penetration depth using static fluid pressure measurements|
|US20040260269 *||Jun 23, 2003||Dec 23, 2004||Yair Assaf||Method for treating false aneurysm and a needle for use in such a method|
|US20050027264 *||Sep 1, 2004||Feb 3, 2005||Fleury Michael T.||Huber needle with anti-rebound safety mechanism|
|US20050065483 *||Sep 24, 2003||Mar 24, 2005||Granit Medical Innovation, Inc.||Medical instrument for fluid injection and related method|
|US20050137531 *||May 28, 2004||Jun 23, 2005||Prausnitz Mark R.||Devices and methods for enhanced microneedle penetration of biological barriers|
|US20050197633 *||Mar 18, 2005||Sep 8, 2005||Schwartz Robert S.||Syringe system|
|US20050288651 *||Sep 2, 2005||Dec 29, 2005||Vantassel Robert A||Apparatus with weeping tip and method of use|
|US20060047253 *||Aug 24, 2004||Mar 2, 2006||Hayman Michael H||Needle assembly|
|US20060212004 *||Mar 15, 2005||Sep 21, 2006||Atil Plaridel C||Medical needle having a closed tip|
|US20070088273 *||Aug 22, 2006||Apr 19, 2007||Ahmad N. Rafi||Method and apparatus for intravascular cannulation|
|US20070213705 *||Mar 7, 2007||Sep 13, 2007||Schmid Peter M||Insulated needle and system|
|US20070225676 *||May 21, 2007||Sep 27, 2007||Prausnitz Mark R||Microneedle drug delivery device|
|US20070250019 *||Jun 21, 2007||Oct 25, 2007||Medical Products Specialists Dba Mps Acacia||Huber needle with anti-rebound safety mechanism|
|US20080228149 *||Mar 16, 2007||Sep 18, 2008||Smiths Medical Asd, Inc.||Blunt cannula for accessing a slit septum|
|US20080281292 *||Jul 23, 2007||Nov 13, 2008||Hickingbotham Dyson W||Retractable Injection Port|
|US20100010413 *||Jul 9, 2009||Jan 14, 2010||Loiterman David A||Needle for Subcutaneous Port|
|US20100324530 *||Feb 3, 2009||Dec 23, 2010||Bernard Hertzog||Hollow needle|
|US20140277052 *||Mar 4, 2014||Sep 18, 2014||Cook Medical Technologies Llc||Tri-fluted vascular access needle|
|DE3927290A1 *||Aug 18, 1989||Feb 21, 1991||Eska Medical & Kunststofftechn||Puncture cannula for blood transfusion - has distal end of reduced dia. and cut obliquely to form sharp point|
|DE4109442A1 *||Mar 22, 1991||Sep 24, 1992||Haindl Hans||Steel syringe for spinal anaesthesia - has external and passage diameters tapering to insertion point and aperture|
|EP0158397A2 *||Apr 1, 1985||Oct 16, 1985||Tom Porcelijn||Instrument for local anaesthesia and accompanying plug|
|EP0158397A3 *||Apr 1, 1985||Oct 1, 1986||Tom Porcelijn||Instrument for local anaesthesia and accompanying plug|
|EP2105155A1 *||Mar 28, 2008||Sep 30, 2009||Bernard Hertzog||Hollow needle|
|WO1992018174A1 *||Apr 17, 1992||Oct 29, 1992||Biotime, Inc.||Cannula|
|WO1996018429A1 *||Dec 14, 1995||Jun 20, 1996||Xiaomeng Liu||Vessel-puncturing cannula|
|WO1999004850A1 *||Jul 22, 1998||Feb 4, 1999||Emed Corporation||Needle for iontophoretic delivery of agent|
|WO2009030788A1 *||Jul 29, 2008||Mar 12, 2009||Gutierrez Manuel Marquez||Hypodermic needle|
|WO2009098024A2 *||Feb 3, 2009||Aug 13, 2009||Bernard Hertzog||Hollow needle|
|WO2009098024A3 *||Feb 3, 2009||Oct 1, 2009||Bernard Hertzog||Hollow needle|
|WO2014145764A2 *||Mar 17, 2014||Sep 18, 2014||C. R. Bard, Inc.||Hydro dissection needle|
|WO2014145764A3 *||Mar 17, 2014||Nov 6, 2014||C. R. Bard, Inc.||Hydro dissection needle|
|Cooperative Classification||A61M5/3291, A61M2230/08, A61M5/32|
|Jun 6, 1987||REMI||Maintenance fee reminder mailed|
|Jun 14, 1987||REMI||Maintenance fee reminder mailed|
|Oct 25, 1987||LAPS||Lapse for failure to pay maintenance fees|
|Jan 12, 1988||FP||Expired due to failure to pay maintenance fee|
Effective date: 19870712